Prostate cancer: trials for referral
1586 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
400 trials shown · Showing the 400 most recently updated of 1586 open trials.
Phase 213 sites
RecruitingUnited States
NCT05691465
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 2108 sites
RecruitingUnited States
NCT06632977
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Alliance for Clinical Trials in Oncology
Pre-treatment window Registry sentence: “REGISTRATION: No prior treatment with EZH inhibitors.”
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingHong Kong SAR China
NCT06360523
To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence
Chinese University of Hong Kong
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 34 sites
RecruitingIsrael, United States
NCT07906717
A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 115 sites
RecruitingAustralia, Spain, United States
NCT05818683
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase7 sites
RecruitingUnited States
NCT06954337
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Memorial Sloan Kettering Cancer Center
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
By invitation onlyUnited States
NCT07328516
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 16 sites
RecruitingUnited Kingdom, United States
NCT07082920
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Janssen Research & Development, LLC
Pre-treatment window Registry sentence: “Any prior treatment with kallikrein-related peptidase 2 (KLK2)-targeted therapy”
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 126 sites
RecruitingAustralia, Canada, Spain, France, United Kingdom, South Korea
NCT05800665
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Genentech, Inc.
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 18 sites
RecruitingSpain, Israel, United States
NCT07746713
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3177 sites
RecruitingAustralia, Belgium, Brazil, Canada, China, Germany
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase9 sites
RecruitingUnited States
NCT04589468
Researching the Effect of Exercise on Cancer
City of Hope Medical Center
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
Not yet recruitingUnited States
NCT07904026
Testosterone-Informed De-Escalation in Metastatic Prostate Cancer (TIDE PC)
University of Nebraska
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 123 sites
RecruitingAustralia, China, France, Japan, Netherlands, United States
NCT06095089
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3142 sites
RecruitingUnited States
NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Alliance for Clinical Trials in Oncology
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingHong Kong SAR China
NCT05443412
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
Chinese University of Hong Kong
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3286 sites
RecruitingArgentina, Austria, Australia, Brazil, Canada, Chile
NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Merck Sharp & Dohme LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
RecruitingUnited States
NCT07574541
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 315 sites
RecruitingPuerto Rico, United States
NCT07723248
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
ORIC Pharmaceuticals
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 214 sites
RecruitingAustralia, China, Japan, United States
NCT07832292
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingCzechia
NCT07253987
Cancer Survivors Program
Masaryk Memorial Cancer Institute
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
RecruitingUnited States
NCT06066437
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
M.D. Anderson Cancer Center
Pre-treatment window Registry sentence: “No prior treatment for prostate cancer including prior surgery (excluding transurethral resection of the prostate \[TURP\]), cryoablation, pelvic lymph node dissection, radiation therapy, hormonal therapy or chemotherapy”
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 15 sites
RecruitingUnited Kingdom, United States
NCT07319871
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
RecruitingUnited States
NCT07667400
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3165 sites
RecruitingAustralia, Belgium, Brazil, Canada, China, Germany
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
Not yet recruitingUnited States
NCT07902921
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3214 sites
RecruitingUnited States
NCT06931340
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Alliance for Clinical Trials in Oncology
Pre-treatment window Registry sentence: “No prior chemotherapy for prostate cancer”
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingChina
NCT06482645
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
Peking University First Hospital
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 1/218 sites
RecruitingUnited Kingdom, United States
NCT06800313
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingFrance
NCT07451002
A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
Janssen Cilag S.A.S.
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- United States246 open trials
- China58 open trials
- Australia54 open trials
- Spain52 open trials
- United Kingdom47 open trials
- France45 open trials
- Italy42 open trials
- Canada41 open trials
- South Korea38 open trials
- Germany38 open trials
- Japan36 open trials
- Taiwan20 open trials
- Poland20 open trials
- Hong Kong SAR China19 open trials
- Netherlands17 open trials
- Belgium16 open trials
- Brazil16 open trials
- Switzerland14 open trials
- Israel13 open trials
- Singapore10 open trials
- Denmark10 open trials
- Sweden9 open trials
- Argentina9 open trials
- Norway9 open trials
- Finland9 open trials
- Mexico8 open trials
- Greece8 open trials
- Austria8 open trials
- Hungary8 open trials
- Malaysia7 open trials
- New Zealand7 open trials
- Czechia7 open trials
- Portugal5 open trials
- Slovakia5 open trials
- India5 open trials
- Puerto Rico4 open trials
- Ireland4 open trials
- Colombia3 open trials
- South Africa3 open trials
- Bulgaria3 open trials
- Chile3 open trials
- Thailand3 open trials
- Russia3 open trials
- Lithuania3 open trials
- Peru2 open trials
- Georgia2 open trials
- Ukraine2 open trials
- Cyprus2 open trials
- Romania1 open trials
- Guatemala1 open trials
- Costa Rica1 open trials
- Saudi Arabia1 open trials
- Iraq1 open trials
- Estonia1 open trials
- Egypt1 open trials
- Moldova1 open trials
- Pakistan1 open trials
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
0 trials · 253 publications · ROR
Deutsches Konsortium für Translationale Krebsforschung
Heidelberg, Germany
0 trials · 103 publications · ROR
The University of Texas MD Anderson Cancer Center
Houston, United States
18 trials · 537 publications · ROR
The University of Texas Southwestern Medical Center
Dallas, United States
3 trials · 354 publications · ROR
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, United States
8 trials · 136 publications · ROR
University College London Hospitals NHS Foundation Trust
London, United Kingdom
10 trials · 141 publications · ROR
University of California, San Francisco
San Francisco, United States
59 trials · 542 publications · ROR
University of North Carolina at Chapel Hill
Chapel Hill, United States
5 trials · 167 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
Phase changed: No phase → Phase 2/3
99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer
NCT06219746 · Phase 2/3 · Finland
Source: ClinicalTrials.govPhase changed: No phase → Phase 1
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
NCT07474051 · Phase 1 · Germany
Source: ClinicalTrials.gov
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
Phase 1Ended 22 Oct 2026
Completed20 participants
NCT07600554
A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer
No phaseEnded 19 Oct 2026
No phaseEnded 6 Oct 2026
Completed230 participants
NCT07181122
Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Phase 2Ended 2 Oct 2026
Completed52 participants
NCT03824652
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
No phaseEnded 1 Oct 2026
Phase 2Ended 8 Sept 2026
No phaseEnded 4 Sept 2026
Completed20 participants
NCT06284304
A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL
No phaseEnded 1 Sept 2026
Phase 2Ended 31 Aug 2026
Phase 2Ended 29 Aug 2026
Completed18 participants
NCT07415135
Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy
No phaseEnded 26 Aug 2026
Completed7 participants
NCT05899361
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
No phaseEnded 23 Aug 2026
Completed180 participants
NCT02766686
Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons
Phase 1/2Ended 17 Aug 2026
Completed52 participants
2024-516976-14-00
A trial to learn how safe AZD9750 is and how well it works in people with metastatic prostate cancer when given with or without other anticancer drugs
No phaseEnded 15 Aug 2026
Completed48 participants
NCT07806539
Hemodynamic Monitoring-Guided Goal-Directed Fluid Therapy in Robotic Radical Prostatectomy
No phaseEnded 10 Aug 2026
Completed2500 participants
NCT03035500
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
Phase 2Ended 6 Aug 2026
Completed22 participants
NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
No phaseEnded 6 Aug 2026
Phase 2Ended 1 Aug 2026
Completed30 participants
NCT04655365
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
Phase 2Ended 31 Jul 2026
Phase 1Ended 29 Jul 2026
Completed35 participants
NCT03269422
Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)
Phase 2Ended 22 Jul 2026
Completed55 participants
NCT06395753
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
No phaseEnded 11 Jul 2026
No phaseEnded 10 Jul 2026
Phase 1Ended 8 Jul 2026
Completed27 participants
NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Phase 2Ended 6 Jul 2026
Completed19 participants
NCT03845751
EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.
No phaseEnded 1 Jul 2026
Completed55 participants
NCT06435871
Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors
No phaseEnded 30 Jun 2026
No phaseEnded 30 Jun 2026
No phaseEnded 30 Jun 2026
Completed999 participants
NCT05467176
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
No phaseEnded 30 Jun 2026
Completed42 participants
NCT06549075
Therapeutic Support to Strengthen Dignity, Mental Well-being and Quality of Life in Acute Palliative Care Patients.
No phaseEnded 30 Jun 2026
Phase 2Ended 30 Jun 2026
Completed42 participants
2022-501139-17-01
A Phase 2 clinical trial of Pembrolizumab in combination with Carboplatin and Cabazitaxel in Aggressive Variant Metastatic Castration Resistant Prostate Cancer
Phase 2Ended 30 Jun 2026
Phase 2/3Ended 26 Jun 2026
Completed80 participants
2024-519358-35-00
An open-label phase 2/3 study to analyse the feasibility and evaluate the safety of intravenous administration of 99mTc-PSMA-T4 in patients with prostate cancer.
No phaseEnded 23 Jun 2026
Completed38 participants
NCT06535802
iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
Phase 2Ended 20 Jun 2026
Completed82 participants
NCT07209865
68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Phase 1/2Ended 19 Jun 2026
Completed44 participants
NCT03543189
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
No phaseEnded 16 Jun 2026
Phase 2Ended 15 Jun 2026
Phase 1Ended 15 Jun 2026
No phaseEnded 15 Jun 2026
Phase 3Ended 11 Jun 2026
Completed131 participants
NCT06754085
Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
No phaseEnded 11 Jun 2026
Completed2 participants
NCT07218718
Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
Phase 2Ended 10 Jun 2026
Completed96 participants
NCT03263650
Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
No phaseEnded 8 Jun 2026
Completed400 participants
NCT06035731
Evaluation of the Medical Service by Socio-aesthetics in Oncology
Phase 4Ended 5 Jun 2026
Completed75 participants
NCT04108208
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Phase 1/2Ended 4 Jun 2026
Completed50 participants
NCT03042468
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
Phase 1/2Ended 2 Jun 2026
Completed98 participants
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
No phaseEnded 30 May 2026
Completed125 participants
NCT03971591
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors
No phaseEnded 29 May 2026
No phaseEnded 28 May 2026
Completed78 participants
NCT07141121
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
Phase 2Ended 28 May 2026
Completed34 participants
NCT04530552
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
Phase 2Ended 26 May 2026
Completed108 participants
NCT01251861
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
No phaseEnded 21 May 2026
Completed21 participants
NCT04556045
Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer
Phase 2Ended 18 May 2026
No phaseEnded 17 May 2026
Completed146 participants
NCT02346253
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
No phaseEnded 15 May 2026
No phaseEnded 15 May 2026
Phase 1Ended 14 May 2026
Completed120 participants
NCT00911118
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
No phaseEnded 10 May 2026
Completed68 participants
NCT06687538
Effect of Education to be Provided to Patients to Undergo TURP With Mobile Application on Patient Outcomes
Not medical advice. fetched 4 Nov 2026